Form 4 for NOC Northrop Grumman
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001628280-23-004322 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-21 | 2023-02-16 | NOC | Jones Thomas H | CVP, Pres Aeronautics Systems | F - Tax | $465.35 | -458 | 3,716 | -11% | -$213.1K |
| D | 2023-02-21 | 2023-02-16 | NOC | Jones Thomas H | CVP, Pres Aeronautics Systems | M - OptEx | $0.00 | +1,324 | 4,174 | +46% | $0 |
| D | 2023-02-21 | 2023-02-17 | NOC | Jones Thomas H | CVP, Pres Aeronautics Systems | S - Sale+OE | $465.44 | -440 | 3,276 | -12% | -$204.8K |
| D | 2023-02-21 | 2023-02-16 | NOC | Jones Thomas H | CVP, Pres Aeronautics Systems | M - OptEx | $0.00 | -1,324 | 17.3K | -7% | $0 |
| DM | 2023-02-21 | 2023-02-16 | NOC | Jones Thomas H | CVP, Pres Aeronautics Systems | A - Grant | $0.00 | +7,307 | 18.6K | +65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-16 | F | D | 458 | $465.35 | 3,716.50 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-16 | M | A | 1,324.04 | $0.00 | 4,174.50 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-17 | S | D | 440 | $465.44 | 3,276.50 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| 4 | Derivative | Restricted Performance Stock Rights | 2023-02-16 | M | D | 1,324.04 | $0.00 | 17,273 | D | — · — to — | 1,324.04 Common Stock | (F3) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
| 5 | Derivative | Restricted Stock Rights | 2023-02-16 | A | A | 2,152 | $0.00 | 7,893 | D | — · — to — | 2,152 Common Stock | (F2) Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/16/23 and will vest on 2/17/26. |
| 6 | Derivative | Restricted Performance Stock Rights | 2023-02-16 | A | A | 5,155.04 | $0.00 | 18,597.04 | D | — · — to — | 5,155.04 Common Stock | (F4) The RPSRs acquired include (i) 486.04 vested RPSRs with respect to the measurement period ended 12/31/22 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/12/20 that resulted in settlement at 158% of the target award; and (ii) 4,669 unvested RPSRs granted under the LTISP on 2/16/23 with a measurement period ending on 12/31/25. A total of 1,324.04 shares were issued in settlement of the 2020 RPSRs with a measurement period that ended 12/31/22, and the target award amount of 838 RPSRs was previously reported in connection with the grant of the 2020 RPSRs. (F3) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |